Does elevated transferrin saturation drive oxidative kidney and vascular injury?

Iron overload, particularly when characterized by elevated transferrin saturation, serves as a significant driver of multi-organ damage through the induction of oxidative stress. This process specifically targets the kidneys and the vasculature, leading to structural and functional impairment.

Mechanistic explanations

• Redox-Active Iron Formation: Under normal physiological conditions, iron is safely sequestered by transferrin. However, when transferrin saturation (TSAT) exceeds approximately 60–70%, the buffering capacity is overwhelmed. This leads to the emergence of non-transferrin-bound iron (NTBI) and its highly reactive subfraction, labile plasma iron (LPI).
• Fenton Chemistry and ROS: These redox-active iron species catalyze Fenton and Haber-Weiss reactions, generating hydroxyl radicals and other reactive oxygen species (ROS). These radicals cause catastrophic damage to lipids (lipid peroxidation), proteins (carbonylation), and DNA (8-OHdG formation).
• Ferroptosis: A critical pathway in this process is ferroptosis, an iron-dependent form of regulated cell death. It is characterized by the accumulation of lipid peroxides—specifically malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)—which leads to the loss of cellular membrane integrity.

Clinical and pathological evidence

• Kidney Tubular Injury: The renal tubules, especially the proximal segment, are highly susceptible to iron-mediated oxidative stress. Research shows that iron deposition in these tissues leads to tubular atrophy and interstitial fibrosis. Clinical markers of this injury include elevated Kidney Injury Molecule-1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL).
• Vascular Injury and Remodeling: Iron-driven oxidative stress promotes vascular calcification and the transformation of vascular smooth muscle cells into osteoblast-like cells. In animal models, iron overload is directly associated with aortic calcium deposition and increased arterial stiffness.
• Causal Risk Factors: Large-scale Mendelian randomization studies have provided evidence that genetically predicted higher iron status is causally linked to an increased risk of chronic kidney disease (CKD) and acute kidney failure. In specific patient populations, such as those with thalassemia or myelodysplastic syndromes, high TSAT is consistently correlated with elevated oxidative stress markers.

Bottom line

• Elevated transferrin saturation triggers the formation of redox-active iron, which drives systemic oxidative stress and ferroptosis. This mechanism leads to progressive kidney tubular injury, interstitial fibrosis, and vascular remodeling, ultimately contributing to the development and progression of renal and cardiovascular disease.